Skip to main content
. 2022 Jan 8;14(1):151. doi: 10.3390/pharmaceutics14010151
AK Actinic keratosis
ASO Antisense oligonucleotide
BCC Basal cell carcinoma
CBM Cutaneous biodistribution method
CLSM Confocal laser scanning microscopy
Cy5 Cyanine 5
DAPI 4′,6-diamidino-2-phénylindole
DEJ Dermo-epithelial junction
DNA Deoxyribonucleic acid
eGFP Enhanced green fluorescent protein
EMA European medical agency
Er: YAG Solid state erbium-doped yttrium aluminium garnet
FDA Food and Drug Administration
FM Fluorescent microscopy
H&E Hematoxylin and eosin
HPLC High-pressure liquid chromatography
ID Intradermal
INF-α Interferon-α
IVT In vitro transcribed
mIgG Mouse immunoglobulin G
mRNA Messenger ribonucleic acid
NGS Normal goat serum
PBS Phosphate buffer saline
PBST Phosphate buffer saline with Tween 20
PD Papillary dermis
PSU Pilosebaceous unit
RD Reticular dermis
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
SCC Squamous cell carcinoma
SC Stratum corneum
SD Sweat duct
siRNA Small interfering ribonucleic acid
VE Viable epidermis
VEGF-A Vascular endothelial growth factor-A